Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0037 USD | +2.78% | -26.00% | -66.06% |
Jun. 01 | Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 25
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
COVID Testing Facilities
100.0
%
| 37 | 100.0 % | 1 | 100.0 % | -98.15% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 37 | 100.0 % | 1 | 100.0 % | -98.15% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Preiner
CEO | Chief Executive Officer | - | 21-04-29 |
Evan Veryard
IRC | Investor Relations Contact | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,019,257 | 25,436,010 ( 94.14 %) | 0 | 94.14 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-66.06% | 97.27K | |
+42.32% | 9.46B | |
+33.70% | 4.36B | |
-40.36% | 2.21B | |
-9.44% | 1.63B | |
-29.34% | 1.2B | |
-42.86% | 974M | |
-11.20% | 936M | |
-46.87% | 739M | |
-31.84% | 581M |
- Stock Market
- Equities
- MEDVF Stock
- Company Medivolve Inc.